Health Insurance Stocks Surge Following Medicare Payment Increase
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy UNH?
Source: seekingalpha
- Payment Increase Impact: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, translating to over $13 billion, led to a significant surge in major insurers' stock prices, with UnitedHealth Group (UNH) rising 9.4%, reflecting market optimism about the healthcare sector's outlook.
- Strong Market Reaction: This payment increase starkly contrasts with the proposed 0.09% hike in January, which had previously caused a sharp decline in insurance stocks, indicating the market's sensitivity to policy changes and their substantial impact on the industry.
- Divergent Analyst Views: While the payment increase is seen as a positive signal, analysts remain cautious about its ability to sustain a long-term rally, noting that medical cost inflation remains between 8-10%, which may lead to ongoing margin pressures.
- Future Outlook: Analysts expect insurers to submit more competitive bids by the June deadline, leveraging this revenue windfall to restore supplemental benefits and recapture lost market share, showcasing the industry's potential recovery capability under supportive policies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 305.980
Low
330.00
Averages
397.82
High
444.00
Current: 305.980
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Medicare Payment Increase: The Centers for Medicare & Medicaid Services confirmed a 2.48% increase in Medicare Advantage payments for 2027, improving from the nearly flat rate proposed in January, alleviating concerns about profit margins.
- Positive Stock Reaction: UnitedHealth's shares surged nearly 8% in after-hours trading on Monday, indicating investor optimism regarding the new payment policy, which could enhance the company's profitability and market confidence.
- Shareholder Structure Analysis: According to TipRanks data, public companies and individual investors hold about 49% of UnitedHealth, while mutual funds and ETFs account for nearly 27% and 22%, respectively, indicating a broad investor base.
- Major Shareholder Insights: Vanguard holds the largest stake at approximately 9%, with the Vanguard Total Stock Market ETF (VTI) owning over 3% and the Vanguard S&P 500 ETF (VOO) holding about 2.6%, reflecting institutional investors' significant interest in the company.
See More
Global Health Research Funding: The United Health Foundation has raised its funding objective for global health research to $337 million, an increase from the previous target of $315 million.
Focus on Health Initiatives: The additional funds are aimed at enhancing health initiatives and addressing critical health challenges worldwide.
Impact on Communities: The funding is expected to support various programs that improve health outcomes in underserved communities globally.
Commitment to Health Equity: This increase reflects a commitment to promoting health equity and advancing research that can lead to better health solutions for diverse populations.
See More
- Payment Increase Impact: The Trump administration's announcement of a 2.48% increase in Medicare Advantage payments for 2027, translating to over $13 billion, led to a significant surge in major insurers' stock prices, with UnitedHealth Group (UNH) rising 9.4%, reflecting market optimism about the healthcare sector's outlook.
- Strong Market Reaction: This payment increase starkly contrasts with the proposed 0.09% hike in January, which had previously caused a sharp decline in insurance stocks, indicating the market's sensitivity to policy changes and their substantial impact on the industry.
- Divergent Analyst Views: While the payment increase is seen as a positive signal, analysts remain cautious about its ability to sustain a long-term rally, noting that medical cost inflation remains between 8-10%, which may lead to ongoing margin pressures.
- Future Outlook: Analysts expect insurers to submit more competitive bids by the June deadline, leveraging this revenue windfall to restore supplemental benefits and recapture lost market share, showcasing the industry's potential recovery capability under supportive policies.
See More
- Shift in Retail Behavior: Retail investors opted to cut risk during Wednesday's market rebound, with ETF outflows reaching their highest levels in a year, indicating a significant departure from the previous 'buying the dip' strategy, which could impact future market stability.
- Market Rally Overview: The Dow Jones Industrial Average surged over 1,300 points, up 2.9%, marking its best single-day performance since April 2025; however, the negative retail flows suggest underlying market confidence may be fragile.
- Sector Flow Analysis: Negative flows were observed across nearly all sectors, with heavy selling in energy and industrial stocks like Exxon Mobil, Chevron, and Occidental Petroleum, reflecting declining confidence among retail investors in these areas.
- Tech Stocks Resilience: Despite the overall market downturn, retail investors showed modest buying interest in large-cap technology stocks such as Tesla, Nvidia, Microsoft, and Meta Platforms, indicating a relative confidence in the tech sector.
See More
- Price Increase Announcement: United Health has raised the price of its Piper and Lerer star ratings from $390 to $399.
- Impact on Consumers: This price adjustment may affect consumers' healthcare costs and choices regarding United Health's services.
See More
- Market Volatility Analysis: Despite the S&P 500 reaching all-time highs over the past 12 months, it has recently dipped 5%, primarily due to concerns over the Iran war, rising fuel prices, and a volatile labor market, indicating instability and investor anxiety.
- American Express Performance: American Express reported fourth-quarter revenue of $17.18 billion, a 10% increase year-over-year, with net income of $2.46 billion, up 13%, while its quarterly dividend yield stands at 1.3%, reflecting strong performance among affluent clientele.
- UnitedHealth Group Challenges: UnitedHealth Group's stock has fallen 46% over the past year, largely due to missing earnings projections in Q1 2025, but it anticipates earnings per share to exceed $17.75 in 2026, indicating potential for recovery.
- Enterprise Products Partners Stability: Enterprise Products Partners generated $13.79 billion in revenue for Q4, slightly down from the previous year, yet net income improved to $1.64 billion, with a robust dividend yield of 5.8%, making it an attractive option for income-focused investors.
See More










